Long-Term Surveillance After Curative Endoscopic Submucosal Dissection for Early Gastric Cancer: Distinct Clinicopathologic Characteristics of Early and Late Metachronous Neoplasia
- 1Division of Gastroenterology, Department of Internal Medicine, Korea University Guro Hospital, Korea University College of Medicine, 148, Gurodong-ro, Guro-gu, Seoul 08308, Republic of Korea
Abstract
Background: Endoscopic submucosal dissection (ESD) is an established treatment for early gastric cancer (EGC) meeting curative resection criteria. We examined clinicopathologic characteristics associated with early and late metachronous neoplasia after curative ESD. Methods: We retrospectively analyzed 185 patients who developed metachronous neoplasia among 1200 patients who underwent curative ESD for EGC. Metachronous neoplasia detected within 60 months was classified as early, and late if it is detected after 60 months. Results: Of the 185 patients with metachronous neoplasia (15.4%), 116 (62.7%) had early and 69 (37.3%) had late metachronous neoplasia; 102 developed cancer and 83 developed adenoma only. Undifferentiated histology of the index lesion was associated with late metachronous neoplasia overall (adjusted odds ratio [OR], 10.73; 95% confidence interval [CI], 1.27–90.35; p = 0.029). In the adenoma subgroup, undifferentiated histology occurred exclusively in patients with late metachronous adenoma (11.1% vs. 0%; p = 0.032), but its adjusted effect could not be estimated because of complete separation. Younger age was associated with late metachronous adenoma (adjusted OR per year, 0.937; 95% CI, 0.881–0.997; p = 0.040). In the cancer subgroup, serum triglyceride was associated with late metachronous cancer in univariable analysis (OR per 10 mg/dL, 1.064; 95% CI, 1.004–1.128; p = 0.036), but not after multivariable adjustment (p = 0.101). Conclusions: More than one-third of metachronous neoplasia were detected beyond five years after curative ESD. Undifferentiated histology was associated with late metachronous neoplasia overall and in the adenoma subgroup, although the latter association could not be adjusted. These findings warrant validation in larger cohorts.
Related
- Clinical parameters associated with metachronous recurrence after curative endoscopic submucosal dissection for early gastric cancer
- Short-Term Safety of Gastric Endoscopic Submucosal Dissection in Patients Aged 80 Years or Older Under a Standardized Inpatient Post-Procedural Surveillance Pathway: Data from a 13-Year Real-World Cohort Study
- Endoscopic flexure straightening: a novel technique for duodenal endoscopic submucosal dissection at difficult flexures.
- A Dual-Pump Switchable Irrigation System for Hemostasis under Gel Immersion during Water Pressure Duodenal Endoscopic Submucosal Dissection.
- Obstructive 12 cm Esophageal Liposarcoma Removed by Endoscopic Submucosal Dissection and Tissue Fragmentation.
BibTeX
@article{joo2026longterm,
title = {{Long-Term Surveillance After Curative Endoscopic Submucosal Dissection for Early Gastric Cancer: Distinct Clinicopathologic Characteristics of Early and Late Metachronous Neoplasia}},
author = {Moon Kyung Joo and Seung Han Kim and Won Shik Kim and Beom Jae Lee},
journal = {Journal of Clinical Medicine},
year = {2026},
month = oct,
doi = {10.3390/jcm15218435},
url = {https://www.mdpi.com/2077-0383/15/21/8435},
note = {CC BY 4.0},
}
RIS
TY - JOUR
TI - Long-Term Surveillance After Curative Endoscopic Submucosal Dissection for Early Gastric Cancer: Distinct Clinicopathologic Characteristics of Early and Late Metachronous Neoplasia
AU - Moon Kyung Joo
AU - Seung Han Kim
AU - Won Shik Kim
AU - Beom Jae Lee
PY - 2026
DA - 2026/10/29
JO - Journal of Clinical Medicine
DO - 10.3390/jcm15218435
UR - https://www.mdpi.com/2077-0383/15/21/8435
AB - Background: Endoscopic submucosal dissection (ESD) is an established treatment for early gastric cancer (EGC) meeting curative resection criteria. We examined clinicopathologic characteristics associated with early and late metachronous neoplasia after curative ESD. Methods: We retrospectively analyzed 185 patients who developed metachronous neoplasia among 1200 patients who underwent curative ESD for EGC. Metachronous neoplasia detected within 60 months was classified as early, and late if it is detected after 60 months. Results: Of the 185 patients with metachronous neoplasia (15.4%), 116 (62.7%) had early and 69 (37.3%) had late metachronous neoplasia; 102 developed cancer and 83 developed adenoma only. Undifferentiated histology of the index lesion was associated with late metachronous neoplasia overall (adjusted odds ratio [OR], 10.73; 95% confidence interval [CI], 1.27–90.35; p = 0.029). In the adenoma subgroup, undifferentiated histology occurred exclusively in patients with late metachronous adenoma (11.1% vs. 0%; p = 0.032), but its adjusted effect could not be estimated because of complete separation. Younger age was associated with late metachronous adenoma (adjusted OR per year, 0.937; 95% CI, 0.881–0.997; p = 0.040). In the cancer subgroup, serum triglyceride was associated with late metachronous cancer in univariable analysis (OR per 10 mg/dL, 1.064; 95% CI, 1.004–1.128; p = 0.036), but not after multivariable adjustment (p = 0.101). Conclusions: More than one-third of metachronous neoplasia were detected beyond five years after curative ESD. Undifferentiated histology was associated with late metachronous neoplasia overall and in the adenoma subgroup, although the latter association could not be adjusted. These findings warrant validation in larger cohorts.
SN - 2077-0383
ER -